Company To Stop Selling Tequin

Jamie Sheller
Attorney
(866) 735-1102 Ext 475
Posted by Jamie ShellerMay 03, 2006 10:30 AM

Bristol-Myers Squibb announced that it will stop manufacturing the antibiotic Tequin. However, the drug is not being pulled from pharmacy shelves right now. The rights to the drug will be returned to a Japanese company, Kyorin Pharmaceutical. A recently published study found that elderly patients using Tequin, were at an increased risk of developing hypoglycemia and hyperglycemia. Those findings prompted an FDA alert and stronger warning labels for the drug. Also, Public Citizen Health Research Group has petitioned the FDA to ban Tequin, saying that it has been linked to at least 20 deaths and nearly 200 hospitalizations.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Philadelphia

InjuryBoard Philadelphia RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Philadelphia is brought to you by Sheller, P.C.

Legal Assistance Center

More Info
Sheller, P.C. (866) 735-1102 Ext 475 www.sheller.com
google
Personal Injury Lawyers Serving: Statewide Pennsylvania, Philadelphia, Norristown, Cheltenham, Chester, Drexel Hill, Folsom, Havertown, King of Prussia, Levittown, Radnor, Springfield, Swarthmore, West Chester, Willow Grove
1528 Walnut Street3rd Floor, Philadelphia, Pennsylvania 19102 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address